The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Compliance with Market Abuse Regualtion

25 Mar 2022 17:45

RNS Number : 1393G
abrdn Latin American Income Fund Ld
25 March 2022
 

abrdn Latin American Income Fund Limited (the "Company")

 

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

25 March 2022

 

The Company announces that it is satisfied, by virtue of the points listed below, that all inside information which the Directors and the Company may have in the closed period (as defined by the EU Market Abuse Regulation) which ends on the date of the announcement of the Half Yearly Financial Report for the six months ended 28 February 2022 has been notified to a Regulated Information Service ("RIS"). The Company is therefore not prohibited from dealing in its own securities during this period.

 

In so stating the Company has regard to:

 

1) the announcement on 7 March 2022 of the net asset value per share as of the close of business on 28 February 2022;

2) the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 7 March 2022 and that to be included in the forthcoming announcement of the Half Yearly Financial Report;

3) the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS;

4) there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities; and

5) there being no unquoted investments within the Company's portfolio.

 

 

abrdn Capital International Limited

Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCEAXDSALDAEFA
Date   Source Headline
13th Jun 20236:00 pmRNSAbrdn Latin American Income Fund
12th Jun 20231:05 pmRNSResult of EGM
12th Jun 20237:30 amRNSSuspension-abrdn Latin American Income Fund
9th Jun 202312:35 pmRNSNet Asset Value(s)
9th Jun 202310:33 amRNSRepayment and Cancellation of Loan Facility
8th Jun 202312:45 pmRNSNet Asset Value(s)
7th Jun 20234:46 pmRNSHolding(s) in Company
7th Jun 202312:01 pmRNSNet Asset Value(s)
7th Jun 202310:55 amRNSMonth End Net Asset Value(s)
6th Jun 202312:13 pmRNSNet Asset Value(s)
5th Jun 20234:18 pmRNSNet Asset Value(s)
2nd Jun 20233:39 pmRNSQuarterly disclosure
2nd Jun 20231:22 pmRNSNet Asset Value(s)
31st May 20231:28 pmRNSNet Asset Value(s)
30th May 20233:54 pmRNSGearing disclosure
30th May 20233:47 pmRNSHolding(s) in Company
30th May 202312:51 pmRNSNet Asset Value(s)
26th May 202312:38 pmRNSNet Asset Value(s)
25th May 20233:55 pmRNSHolding(s) in Company
25th May 202312:34 pmRNSNet Asset Value(s)
24th May 202311:59 amRNSNet Asset Value(s)
23rd May 202312:21 pmRNSNet Asset Value(s)
22nd May 20233:21 pmRNSGearing disclosure
22nd May 202312:25 pmRNSNet Asset Value(s)
19th May 20231:49 pmRNSNet Asset Value(s)
18th May 202312:50 pmRNSNet Asset Value(s)
18th May 202310:14 amRNSPortfolio disclosure
18th May 20237:00 amRNSRecommended Proposals for Winding-Up of Company
17th May 202312:37 pmRNSNet Asset Value(s)
16th May 202312:06 pmRNSNet Asset Value(s)
15th May 20232:55 pmRNSGearing disclosure
15th May 202311:41 amRNSNet Asset Value(s)
12th May 202312:14 pmRNSNet Asset Value(s)
11th May 202312:35 pmRNSNet Asset Value(s)
11th May 202311:57 amRNSHolding(s) in Company
10th May 20231:07 pmRNSNet Asset Value(s)
9th May 20235:38 pmRNSGearing disclosure
9th May 202311:53 amRNSNet Asset Value(s)
5th May 20236:15 pmRNSMonth End Net Asset Value(s)
5th May 20231:12 pmRNSNet Asset Value(s)
4th May 202312:36 pmRNSNet Asset Value(s)
3rd May 202312:44 pmRNSNet Asset Value(s)
2nd May 20234:05 pmRNSGearing disclosure
28th Apr 20231:00 pmRNSNet Asset Value(s)
27th Apr 20231:17 pmRNSNet Asset Value(s)
26th Apr 20231:12 pmRNSNet Asset Value(s)
25th Apr 202312:45 pmRNSNet Asset Value(s)
24th Apr 20232:26 pmRNSGearing disclosure
24th Apr 202312:19 pmRNSNet Asset Value(s)
21st Apr 202312:58 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.